Mechanism: Age-related increase in gut-derived PAA crosses an upregulated blood-brain barrier, activating GPR35 on amygdala CRF+ neurons, leading to hyperexcitability and impaired fear extinction. Readout: Readout: Interventions like diet restriction or GPR35 antagonism normalize neuronal excitability, reducing anxiety and restoring fear extinction success.
Hypothesis
Age‑related enrichment of gut‑derived phenylacetic acid (PAA) crosses the blood‑brain barrier and directly potentiates CRF‑expressing neurons in the central amygdala, blunting fear extinction and driving anxiety‑like behavior.
Mechanistic rationale
- Microbial source – Aging shifts the colonic microbiota toward increased phenylalanine‑degrading taxa (e.g., Clostridium sporogenes, Escherichia coli). These microbes convert dietary phenylalanine to PAA, which accumulates in plasma【https://doi.org/10.1101/2023.11.17.567594】.
- Blood‑brain access – PAA is a small, monocarboxylic acid that utilizes MCT1 transporters expressed on cerebral endothelium. Aging upregulates MCT1 in the amygdala vasculature, enhancing PAA entry【https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1697200/full】.
- Neuronal target – CRF+ cells in the central amygdala express high levels of PKA‑anchoring proteins. PAA acts as a weak agonist of the G‑protein coupled receptor GPR35, which is enriched on these neurons and raises intracellular cAMP, activating PKA【https://pmc.ncbi.nlm.nih.gov/articles/PMC3583817/】.
- Electrophysiological outcome – PKA phosphorylation potentiates NMDA‑receptor currents and reduces GABAergic inhibitory tone, producing hyperexcitability that impairs extinction learning.
- Behavioral read‑out – Elevated PAA predicts reduced freezing suppression during extinction recall and increased anxiety in the elevated plus maze.
Experimental plan
- Metabolite quantification – Collect plasma and microdialysate from amygdala of young (3 mo) and aged (24 mo) mice; measure PAA by LC‑MS/MS.
- Microbial manipulation – Treat aged mice with a phenylalanine‑restricted diet or a bacteriophage cocktail targeting phenylalanine‑degrading strains; verify fecal PAA drop.
- Pharmacological blockade – Administer the GPR35 antagonist CID‑2745687 intracerebroventricularly during extinction training.
- Electrophysiology – Perform whole‑cell patch clamp on CRF‑tdTomato‑positive amygdala slices; assess NMDA‑EPSC amplitude and GABA‑IPSC frequency before and after PAA application.
- Behavior – Run fear conditioning followed by extinction training and recall; compare freezing scores across groups.
Predictions
- Aged mice will show ~2‑fold higher plasma PAA than young mice.
- Lowering microbial PAA production or blocking GPR35 will restore NMDA/ GABA balance in CRF+ neurons and rescue extinction performance.
- Vagotomy will not affect the PAA‑driven phenotype, confirming a humoral route.
Falsifiability
If plasma PAA levels do not correlate with amygdala CRF excitability, or if GPR35 antagonism fails to modify extinction despite confirmed target engagement, the hypothesis is refuted.
Broader impact
Demonstrating a gut‑to‑brain metabolic gate on limbic circuitry would invert the conventional top‑down view of stress‑aging interactions and prioritize microbiome‑directed metabolites as primary targets for interventions that improve emotional resilience in old age.
Comments
Sign in to comment.